Navigation Links
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
Date:8/27/2012

d effective strategies by clinical phase wise endpoint analysis of clinical trials. This can help in reducing the drug's time to market.

- Exploit strategies for designing of clinical trials by identifying the advantages and disadvantages involved with the use of specific endpoints.

1 Table of Contents1 Table of Contents 51.1 List of Tables 81.2 List of Figures 102 Introduction 133 Clinical Trials Endpoints in Respiratory Diseases - An Overview 143.1 Introduction 143.2 Types of Endpoints 143.2.1 Primary Endpoints 143.2.2 Secondary Endpoints 143.2.3 Surrogate Endpoints 154 Endpoints - Clinical Trials in Asthma - Marketed and Pipeline Products Assessment 164.1 Introduction 164.2 Primary Endpoints Used in Asthma Clinical Trials 204.2.1 Pulmonary Function Tests: 204.2.2 Vital Signs and Physical Activity 204.2.3 Biomarkers 204.2.4 Serious Adverse Events 204.3 Secondary Endpoints Used in Asthma Clinical Trials 214.3.1 Pharmacokinetics and Pharmacodynamics 214.3.2 Quality of Life Scores 214.3.3 Clinical Laboratory Tests – Biochemistry and Serum Hematology 214.3.4 Use of Rescue Medication 214.4 Asthma Therapeutics – Major Marketed Drugs 214.4.1 Singulair (Montekeulast Sodium) 214.4.2 Accolate Accoleit, Vanticon (Zafirlukast) 224.4.3 Zyflo (Zileuton) 234.4.4 Foradil (Formoterol Fumarate Inhalation Powder) 244.4.5 Symbicort (budesonide/formoterol fumarate dihydrate inhalation aerosol) 254.4.6 Xolair (Omalizumab) 274.4.7 Serevent Diskus (Salmaterol Xinafoate Inhalation Powder) 284.4.8 Advair Diskus (Fluticasone Propionate and Salmeterol Inhalation Powder) 294.5 Asthma Therapeutics – Promising Drugs under Clinical Development 304.5.1 Daxas (Roflumilast) (Daxas, APTA 2217, B9302-107, BY 217, BYK 20869) 304.6 Phase III Clinical Trial Analysis 314.6.1 Completed Trial Analysis 314.6.2 Active Trial Analysis 354.6.3 Terminated Trial Analysis 394.7 Phase II Clinical Trial Analysis 414.7.1 Completed Trial Analysis 414.7.2 Active Trial Analysis 454.7.3 Te
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
2. As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing
3. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
4. VolitionRX to Begin Prospective Clinical Trial in Colon Cancer
5. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
6. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
7. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
8. Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
9. Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients with Eosinophilic Esophagitis
10. MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
11. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... September 2, 2014 According ... Market Research "Latin America Home Healthcare Market (By ... Healthcare Devices, Mobility Assist Devices and Medical Supplies; ... Infusion Therapy and Unskilled Home Healthcare Services) - ... 2014 - 2020" the Latin American Home Healthcare ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014   Santa ... now offering a special promotion for Invisalign. Invisalign is ... brackets and wires. It is often the orthodontic treatment ... the convenience and aesthetics of it. For a limited ... is a significant savings from the usual cost. This ...
(Date:9/2/2014)... España, September 2, 2014 ... fibrilación atrial muestran agentes antitrombóticos no utilizados óptimamente ... -- Las presentaciones de GARFIELD-AF en el ... tratamiento y los resultados de pacientes en riesgo ... --    Los datos de casi ...
Breaking Medicine Technology:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11
... , WASHINGTON, Dec. 14 ... counsel on global and domestic communications and issues management, ... PositiveID Corporation (Nasdaq: PSID ) to serve as ... will conduct media relations for PositiveID,s corporate communications and ...
... , NEW HAVEN, Conn., ,Dec. 14 /PRNewswire-FirstCall/ ... today announced that it had received a complete response ... related to its New Drug Application ("NDA") for Onrigin(TM) ... indicates that the FDA cannot approve the Company,s NDA ...
Cached Medicine Technology:Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3
(Date:9/2/2014)... A New York City based company is ... yet revolutionary, product that will have far-reaching, ... care costs for Americans. , REMIND-A-CAP™ is ... control in the user's hands. It's a simple device ... date of intake by simply turning a knob. No ...
(Date:9/2/2014)... Welcome to Arthritis Awareness Month ... Canadians living with the disease, The Arthritis Society is ... series featuring well-known Canadians from different walks of life ... Lloyd Robertson , veteran news anchor , ... ,      Amy Cotton , two-time Olympic wrestler ...
(Date:9/2/2014)... A little white pill may help scientists learn why ... their peers, even if their lungs are relatively healthy. ... marketed as Revatio to treat pulmonary hypertension and Viagra ... of over-the-counter antioxidants will help them identify the root ... for these patients. , "We want to understand ...
(Date:9/2/2014)... Cardiology Congress in Barcelona shows that having a family ... motivate people to follow healthy lifestyles. , Researchers ... online tool that engages people presenting their personal CVD ... the hypothesis that those who have a family history ... and blood pressure checks and be motivated to adopt ...
(Date:9/2/2014)... be a new salve to dominate medicine cabinets of the ... Salamanders may not be the cuddliest of animals, but they ... damaged body parts. Now, a new report published in the ... , identifies a small protein (called a "peptide") from the ... the secret of this amazing wound healing trick in humans. ...
Breaking Medicine News(10 mins):Health News:REMIND-A-CAP™ , A New York City Based Company Invents Groundbreaking Prescription Cap to Curb Non-Adherence 2Health News:‘Voices of Arthritis’ Launches Awareness Month 2Health News:‘Voices of Arthritis’ Launches Awareness Month 3Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 2Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 3Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 4Health News:Family history of cardiovascular disease is not enough to motivate people to follow healthy lifestyle 2Health News:Salamander skin peptide promotes quick and effective wound healing in mice 2
... finds chlorthalidone most likely to prevent heart failure, ... Tried-and-true diuretics maintain their status as the best ... high blood pressure, new research concludes. , The ... a calcium channel blocker, an ACE inhibitor and ...
... Nov. 18 The U.S. Agency for International Development (USAID) ... up with Chicago Cubs Charities Nov. 17 to donate $100,000 ... Basic School and Education Center for Integrated Health (CESI). , ... and...Loyola and Creighton (universities) to help children and their families ...
... Release Statewide Data , HARRISBURG, Pa., Nov. 18 Pennsylvania is ... and adults living with autism, according to the Pennsylvania Autism Census ... , "With the release of this report, Pennsylvania becomes the first ... to meet the needs of the rapidly growing population of children ...
... The National Patient Safety Foundation (NPSF) today issued the following position ... The National Patient Safety Foundation recognizes vaccine-preventable, ... and supports mandatory, influenza vaccination of ... patients, health care workers, and the community. NPSF appreciates, ...
... Nov. 18 Hospice workers have seen patients hang onto ... from the Frances Payne Bolton School of Nursing and the ... will study what drives the dying to resolve unfinished business. ... Prince-Paul from nursing and Julie Exline from arts and sciences ...
... at Mount Sinai School of Medicine set out to ... years: How do dietary restrictionand the reverse, overconsumptionproduce protective ... in a two-part study led by Charles Mobbs, PhD, ... at Mount Sinai School of Medicine, published in the ...
Cached Medicine News:Health News:Diuretics Still Best Treatment for High Blood Pressure 2Health News:USAID, Cubs Charities Make a Grand Slam for Health and Basic Education 2Health News:PA Governor Rendell: New Report Shows Demand for Autism Services will Continue to Rise 2Health News:National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 2Health News:National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 3Health News:Research Collaboration Focuses on Unfinished Business at the End of Life 2Health News:Scientists find molecular trigger that helps prevent aging and disease 2Health News:Scientists find molecular trigger that helps prevent aging and disease 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: